Cross Country Healthcare (CCRN) Tops Q4 EPS by 10c, Offers Guidance
Cross Country Healthcare (NASDAQ: CCRN) reported Q4 EPS of $0.19, $0.10 better than the analyst estimate of $0.09. Revenue for the quarter came in at $215.6 million versus the consensus estimate of $196.42 million.
GUIDANCE:
Cross Country Healthcare sees Q1 2021 EPS of $0.32-$0.37, versus the consensus of $0.07. Cross Country Healthcare sees Q1 2021 revenue of $280-295 million, versus the consensus of $201 million.
For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.
